These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7816192)

  • 1. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease.
    Vickers JC; Riederer BM; Marugg RA; Buée-Scherrer V; Buée L; Delacourte A; Morrison JH
    Neuroscience; 1994 Sep; 62(1):1-13. PubMed ID: 7816192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
    Su JH; Cummings BJ; Cotman CW
    Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease.
    Thangavel R; Sahu SK; Van Hoesen GW; Zaheer A
    Neuroscience; 2009 May; 160(2):427-33. PubMed ID: 19250962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's disease.
    Cork LC; Sternberger NH; Sternberger LA; Casanova MF; Struble RG; Price DL
    J Neuropathol Exp Neurol; 1986 Jan; 45(1):56-64. PubMed ID: 3510274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal distribution of neurofilament L in neurons with Alzheimer's disease.
    Nakamura Y; Hasimoto R; Kashiwagi Y; Miyamae Y; Shinosaki K; Nishikawa T; Hattori H; Kudo T; Takeda M
    Neurosci Lett; 1997 Apr; 225(3):201-4. PubMed ID: 9147405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease.
    Morrison JH; Lewis DA; Campbell MJ; Huntley GW; Benson DL; Bouras C
    Brain Res; 1987 Jul; 416(2):331-6. PubMed ID: 3113670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?
    Ransmayr G; Cervera P; Hirsch EC; Berger W; Fischer W; Agid Y
    Neuroscience; 1992; 47(4):843-51. PubMed ID: 1374541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.
    Shepherd CE; Thiel E; McCann H; Halliday GM
    Neurobiol Dis; 2001 Feb; 8(1):136-46. PubMed ID: 11162247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus.
    Holzer M; Gärtner U; Stöbe A; Härtig W; Gruschka H; Brückner MK; Arendt T
    Acta Neuropathol; 2002 Nov; 104(5):471-81. PubMed ID: 12410395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic cytochrome c immunolabelling in dystrophic neurites in Alzheimer's disease.
    Woodhouse A; Vickers JC; Dickson TC
    Acta Neuropathol; 2006 Oct; 112(4):429-37. PubMed ID: 16855832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease.
    Vickers JC; Delacourte A; Morrison JH
    Brain Res; 1992 Oct; 594(2):273-8. PubMed ID: 1450952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease.
    Dickson TC; King CE; McCormack GH; Vickers JC
    Exp Neurol; 1999 Mar; 156(1):100-10. PubMed ID: 10192781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia.
    Duong T; De Rosa MJ; Poukens V; Vinters HV; Fisher RS
    Acta Neuropathol; 1994; 87(5):493-503. PubMed ID: 8059602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cellular basis for the relative resistance of parvalbumin and calretinin immunoreactive neocortical neurons to the pathology of Alzheimer's disease.
    Sampson VL; Morrison JH; Vickers JC
    Exp Neurol; 1997 May; 145(1):295-302. PubMed ID: 9184132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: immunoreactivity of neurofibrillary tangles with anti-neurofilament and anti-paired helical filament antibodies.
    Rasool CG; Abraham C; Anderton BH; Haugh M; Kahn J; Selkoe DJ
    Brain Res; 1984 Sep; 310(2):249-60. PubMed ID: 6207891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-3 cleaved spectrin colocalizes with neurofilament-immunoreactive neurons in Alzheimer's disease.
    Ayala-Grosso C; Tam J; Roy S; Xanthoudakis S; Da Costa D; Nicholson DW; Robertson GS
    Neuroscience; 2006 Aug; 141(2):863-874. PubMed ID: 16750894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate-, glutaminase-, and taurine-immunoreactive neurons develop neurofibrillary tangles in Alzheimer's disease.
    Kowall NW; Beal MF
    Ann Neurol; 1991 Feb; 29(2):162-7. PubMed ID: 1672808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles.
    Sugata H; Matsuo K; Nakagawa T; Takahashi M; Mukai H; Ono Y; Maeda K; Akiyama H; Kawamata T
    Neurosci Lett; 2009 Aug; 459(2):96-9. PubMed ID: 19414059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hippocampal GABABR1 subunit expression in Alzheimer's patients: association with Braak staging.
    Iwakiri M; Mizukami K; Ikonomovic MD; Ishikawa M; Hidaka S; Abrahamson EE; DeKosky ST; Asada T
    Acta Neuropathol; 2005 May; 109(5):467-74. PubMed ID: 15759131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of calbindin D28K-immunoreactive cells and neuropathological changes in the hippocampal formation of Alzheimer's disease.
    Iritani S; Niizato K; Emson PC
    Neuropathology; 2001 Sep; 21(3):162-7. PubMed ID: 11666012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.